Abivax S.A.

Abivax S.A. - ROEverified

AAVXF

Price:

$101.25

Market Cap:

$6.78B

Abivax S.A., a French biopharmaceutical firm, specializes in the discovery and enhancement of pharmaceutical treatments targeting inflammatory conditions, infectious illnesses, and various forms of cancer. The company's flagship compound, ABX464, is currently undergoing Phase IIb clinical evaluations for ulcerative colitis, Crohn's disease, and COVID-19. It is also being assessed in Phase IIa trials for rheumatoid arthritis, and has successfully concluded Phase IIa studies demonstrating viral remission in individuals with HIV. Additionally, Abivax is advancing ABX 196, an investigational immune-enhancing agent, through Phase 1/2 clinical trials for its potential application in treating hepat...[Read more]

Industry

Biotechnology

IPO Date

2016-09-27

Stock Exchange

OTC

Ticker

AAVXF

The ROE as of June 2026 (TTM) for Abivax S.A. (AAVXF) is -165.19%

According to Abivax S.A.’s latest financial reports and current stock price. The company's current ROE is -165.19%. This represents a change of 369.95% compared to the average of -35.15% of the last 4 quarters.

Abivax S.A. (AAVXF) Historical ROE (quarterly & annually)

How has AAVXF ROE performed in the past?

The mean historical ROE of Abivax S.A. over the last ten years is -215.61%. The current -165.19% ROE has changed -23.38% with respect to the historical average. Over the past ten years (40 quarters), AAVXF's ROE was at its highest in in the June 2022 quarter at 3.93%. The ROE was at its lowest in in the December 2022 quarter at -2140.97%.

Quarterly (TTM)
Annual

Average

-215.61%

Median

-119.54%

Minimum

-844.90%

Maximum

-23.29%

Abivax S.A. (AAVXF) ROE by Quarter and Year

Discovering the peaks and valleys of Abivax S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 476.15%

Maximum Annual ROE = -23.29%

Minimum Annual Increase = -91.08%

Minimum Annual ROE = -844.90%

Quarterly (TTM)
Annual
YearROEChange
2025-73.84%-83.00%
2024-434.26%476.15%
2023-75.37%-91.08%
2022-844.90%416.13%
2021-163.70%-21.97%
2020-209.78%-19.32%
2019-260.03%469.49%
2018-45.66%96.03%
2017-23.29%-7.67%
2016-25.23%13.43%

Abivax S.A. (AAVXF) Average ROE

How has AAVXF ROE performed in the past?

The current ROE of Abivax S.A. (AAVXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-194.49%

5-year avg

-318.41%

10-year avg

-215.61%

Abivax S.A. (AAVXF) ROE vs. Peers

How is AAVXF’s ROE compared to its peers?

Abivax S.A.’s ROE is greater than Axsome Therapeutics, Inc. (-260.01%), greater than Merus N.V. (-50.79%), greater than Rhythm Pharmaceuticals, Inc. (-203.25%), greater than Nuvalent, Inc. (-42.78%), greater than CRISPR Therapeutics AG (-30.88%), greater than Arcellx, Inc. (-55.42%), less than Cytokinetics, Incorporated (139.66%), less than Jazz Pharmaceuticals plc (0.71%), greater than Metsera, Inc. (-79.64%), greater than Arrowhead Pharmaceuticals, Inc. (-55.45%),

Build a custom stock screener for Abivax S.A. (AAVXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abivax S.A. (AAVXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Abivax S.A.'s ROE?

How is the ROE calculated for Abivax S.A. (AAVXF)?

What is the highest ROE for Abivax S.A. (AAVXF)?

What is the 3-year average ROE for Abivax S.A. (AAVXF)?

What is the 5-year average ROE for Abivax S.A. (AAVXF)?

How does the current ROE for Abivax S.A. (AAVXF) compare to its historical average?